Release date: 2015-08-18
Wu Mengchao, an academician of the Chinese Academy of Sciences and a famous expert in hepatobiliary surgery, said at the Precision Medical Branch of the China National Institute of Biotechnology and Biotechnology recently that the National Hepatocellular Science Center is expected to appear in Anting Town, Jiading District, Shanghai in October this year, while the Second Military Medical University’s Eastern Hepatobiliary The surgical hospital will also be relocated to Anting during the year, and the number of beds will be expanded from the original 700 to 1,500.
At the same time, the Heping Hospital of the Eastern Hepatobiliary Surgery Hospital will also set up a liver cancer scientific research center jointly established by Wu Mengchao and other six academicians. The Shanghai Cell Therapy Engineering Technology Research Center will be established at a distance from the hospital. immunity therapy.
According to previous news, the “National Liver Cancer Science Center†was established by the National Development and Reform Commission, and the Second Military Medical University jointly established with Fudan University and Shanghai Jiaotong University. On the morning of April 1, 2012, the construction started on the west side of the new hospital area of ​​the Eastern Hepatobiliary Surgery Hospital of Anting Town, Jiading District, Shanghai. It is the second national science center approved by the National Development and Reform Commission after the National Nanoscience Center. The investment is about 150 million yuan. The center will focus on the goal of significantly reducing the incidence and mortality of liver cancer in China, focusing on key scientific and technological issues in the field of liver cancer research, and carrying out basic and applied basic research on liver cancer. The research focuses on: early warning and prevention of hepatitis-cirrhosis to liver cancer development, screening of liver cancer markers and its application in early diagnosis, molecular typing and personalized treatment, molecular mechanism of liver cancer development, drug target identification and targeting Intervention study, molecular mechanism and intervention technology of liver cancer recurrence and metastasis, systemic regulation of host and microenvironment, exploration of new ways of liver cancer biotherapy, comprehensive treatment of liver cancer and evaluation and optimization of new treatment plan.
The center is mainly composed of diagnostic marker screening and molecular typing laboratory, pathogen and host interaction analysis laboratory, molecular network regulation research laboratory, drug target discovery and research and development laboratory, cell therapy research laboratory, and evidence-based medicine research laboratory. The core platform and the resource preservation and data link application center, the animal center, and the pilot platform are composed of three public auxiliary research and development platforms.
Source: Medical Valley
Maitake Mushrooms,Grifola Frondosa,Grifola Frondosa Mushroom,Champignon Grifola Frondosa
Guangyun Agricultural Biotechnology (Jiangsu) Co., Ltd , https://www.7-mushrooms.com